D-1 dopaminergic and beta-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM

• Published in: Journal of neurochemistry Vol. 47; no. 3; p. 715
• Main Authors: Balmforth, A J, Ball, S G, Freshney, R I, Graham, D I, McNamee, H B, Vaughan, P F
• Format: Journal Article
• Language: English
• Published: England 01.09.1986
• Subjects: Adenylyl Cyclases - metabolism; Astrocytoma - enzymology; Cell Line; Clone Cells - enzymology; Cyclic AMP - biosynthesis; Dopamine - pharmacology; Flupenthixol - pharmacology; Humans; Isoproterenol - pharmacology; Norepinephrine - pharmacology; Propranolol - pharmacology; Receptors, Adrenergic, beta - drug effects; Receptors, Adrenergic, beta - physiology; Receptors, Dopamine - drug effects; Receptors, Dopamine - physiology; Receptors, Dopamine D1
• ISSN: 0022-3042; 1471-4159
• DOI: 10.1111/j.1471-4159.1986.tb00670.x

Clones have been isolated from the human astrocytoma cell line G-CCM. Homogenates of clone D384 contain an adenylate cyclase that is stimulated by 3,4-dihydroxyphenylethylamine (dopamine), noradrenaline, and isoprenaline with Ka apparent values of 4, 56, and 2.7 microM, respectively. The Ka apparent value for dopamine was increased by the D-1 antagonist cis-flupenthixol, 25 and 100 nM, to 23 and 190 microM, respectively, but was unaffected by propranolol (1 microM). Noradrenaline stimulation of adenylate cyclase was only partially inhibited by either propranolol (10 microM) or cis-flupenthixol (1 microM). Propranolol (10 microM), but not cis-flupenthixol (1 microM), prevented stimulation by isoprenaline. The stimulation of adenylate cyclase by dopamine and noradrenaline remained unchanged in the presence of phentolamine (1 microM) and sulpiride (1 microM). These results suggest that clone D384 contains both D-1 dopaminergic and beta-adrenergic receptors coupled to adenylate cyclase. Dopamine stimulates D384 adenylate cyclase through D-1 receptors, isoprenaline via beta-receptors, and noradrenaline through both receptors.